Notably, exogenous rIL-9 inhibited tumor growth in Rag1(−/−) mice but not in mast-cell-deficient mice, indicating that IL-9 targets in this context include mast cells but not T or B cells. This evidence concerns the gene RAG1 and neoplasm.